Candriam S.C.A. Deciphera Pharmaceuticals, Inc. Transaction History

Candriam S.C.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $4.15 Million - $6.71 Million	-604,379 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$7.7 - $37.13 $798,782 - $3.85 Million	-103,738 Reduced 14.65%	604,379 $5.91 Million
Q2 2021 Jul 20, 2021	BUY	$32.73 - $47.95 $17.4 Million - $25.5 Million	531,462 Added 300.85%	708,117 $25.9 Million
Q1 2021 Apr 29, 2021	BUY	$40.39 - $56.73 $767 - $1,077	19 Added 0.01%	176,655 $9.68 Million
Q4 2020 Jan 22, 2021	SELL	$51.77 - $66.18 $3.77 Million - $4.82 Million	-72,883 Reduced 29.21%	176,636 $10.1 Million
Q3 2020 Oct 19, 2020	SELL	$43.8 - $58.16 $96,184 - $127,719	-2,196 Reduced 0.87%	249,519 $12.8 Million
Q2 2020 Jul 23, 2020	BUY	$37.05 - $65.03 $9.33 Million - $16.4 Million	251,701 Added 1797864.25%	251,715 $15 Million
Q1 2020 May 26, 2020	BUY	$33.63 - $69.4 $470 - $971	14 New	14 $1,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.